Tg Therapeutics (TGTX) Restructuring Costs (2011 - 2020)

Tg Therapeutics' Restructuring Costs history runs 10 years deep, the most recent figure standing at $16.2 million for Q4 2020.

• In Q4 2020, Restructuring Costs rose 452.33% year-over-year to $16.2 million; the TTM figure through Dec 2020 stood at $41.5 million (up 336.85% YoY), while the FY2020 annual figure was $41.5 million, up 336.9% from the prior year.
• Restructuring Costs was $16.2 million for Q4 2020 at Tg Therapeutics, up from $11.6 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $16.2 million in Q4 2020 to a low of $1.1 million in Q1 2016.
• Historically, Restructuring Costs has averaged $3.5 million across 5 years, with a median of $1.9 million in 2018.
• The sharpest annual moves came in 2019 and 2020: Restructuring Costs decreased 8.02% in 2019, then soared 452.33% in 2020.
• A 5-year view of Restructuring Costs shows it stood at $1.3 million in 2016, then surged by 33.55% to $1.8 million in 2017, then fell by 6.0% to $1.7 million in 2018, then surged by 76.04% to $2.9 million in 2019, then jumped by 452.33% to $16.2 million in 2020.
• The last three Restructuring Costs figures came in at $16.2 million (Q4 2020), $11.6 million (Q3 2020), and $8.6 million (Q2 2020), per Business Quant data.